Pulmonary vascular disease & thromboembolism
Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism: insights from a national database
Study context
- Population
- Hospitalizations with acute pulmonary embolism (PE), Nationwide Readmissions Database (US), 2016–2020
- Participants
- 920,770 hospitalizations
- Outcome
- Temporal trends in utilization of advanced PE therapies
Methodological detailsnational database
- National database
Main finding
As reported in the abstract
Temporal trends in advanced PE therapy use, 2016-2020
- Overall increase in use of advanced PE therapies, mainly systemic thrombolytics and catheter-directed therapies
- Incremental increase in extracorporeal membrane oxygenation cannulation
- Decline in inferior vena cava filter use
- No change in surgical embolectomy use
- Increase in advanced therapies at urban teaching but not urban non-teaching hospitals
Observational data: associations, not effects.
Further findings
Proportion diagnosed with high-risk PE
- Increased over the study years
In-hospital mortality and 90-day unplanned readmission
- No change in unadjusted or adjusted in-hospital mortality
- 90-day unplanned readmission rate declined
Original publication
Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism: insights from a national database. Eur Heart J Acute Cardiovasc Care. Published 7 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →